USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Mccann Associates Inc
Address:
3139 South Wayne Road
Wayne, MI 48184
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $141,356.00 3

Award List:

BIOLOGICALLY STABLE HEPARIN DERIVATIVES

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$42,000.00
Agency:
HHS
Principal Investigator:
Daisy s mccann phd
Abstract:
A series of covalent heparin-protein complexes with prolonged in vivo half-lives of the heparin moiety and high anticoagulant activity will be developed. a series of proteins covering a broad range of molecular weights and isoelectric points will be chosen for these conjugates. various conjugation… More

DNA PROBE ASSAY FOR B. BURGDORFERI--LYME DISEASE

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$49,696.00
Agency:
HHS
Principal Investigator:
Abstract:
Lyme disease, a multisystemic disorder, begins with the transmission of the bacterium, borrelia burgdorferi, at the site of a tick bite and progresses in stages to present dermatological, neurological, and arthritic syndromes. the objectives of this project are to: (1) develop a commercially viable… More

ENZYME TAGGING OF MALIGNANT CERVICAL EPITHELIAL CELLS

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$49,660.00
Agency:
HHS
Principal Investigator:
Daisy S Mccann
Abstract:
The long-term aim of this project is the development of an automated screening instrument (reagents integrated with instrumentation) for pap smears. phase i will be used to demonstrate the feasibility of using 2 monoclonal antibodies against 2 enzymes as the key reagents in the system. briefly the… More